Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. While effective treatments like chemotherapy have increased survival rates, some can have long-term side effects, including cardiovascular complications.
This article explores the link between DLBCL treatment and heart problems, focusing on the most common drugs, associated symptoms, and potential complications. We'll also provide recommendations for DLBCL patients and caregivers to help minimize cardiovascular risks.
The good news: many DLBCL patients achieve remission with treatment. However, some chemotherapy, particularly anthracyclines like doxorubicin, can damage heart muscle cells, leading to a condition called cardiotoxicity. This damage can be cumulative, even with moderate doses, and can weaken the heart and affect its normal function.
Early detection of heart problems is crucial. Here are some common symptoms of cardiovascular complications to be aware of:
Cardiovascular complications associated with DLBCL treatment can range from mild to severe and ultimately lead to heart failure. Some of the most reported complications include:
During and after DLBCL treatment, it is crucial to maintain open communication with your doctor. This will ensure that any potential issues can be identified early on and addressed. Here's what you can do to minimize cardiovascular risks:
Regular monitoring with echocardiograms is crucial. If your echocardiogram results show any abnormalities, your doctor may recommend consulting with a cardiologist or a cardio-oncologist for a more specialized assessment and personalized management plan for your heart health.
While some DLBCL treatments can increase the risk of heart problems, early detection, and proactive management strategies play a significant role in minimizing these risks. By working closely with your doctor and adopting a heart-healthy lifestyle, you can significantly improve your long-term health and well-being after DLBCL treatment.
If you want to learn more about navigating your health living with DLBCL and latest treatment advances, make sure to check out our Events Page and join us in our next webinar, CAR T-Cell Therapy Advances in Large B-Cell Lymphoma.
Sources:
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. While effective treatments like chemotherapy have increased survival rates, some can have long-term side effects, including cardiovascular complications.
This article explores the link between DLBCL treatment and heart problems, focusing on the most common drugs, associated symptoms, and potential complications. We'll also provide recommendations for DLBCL patients and caregivers to help minimize cardiovascular risks.
The good news: many DLBCL patients achieve remission with treatment. However, some chemotherapy, particularly anthracyclines like doxorubicin, can damage heart muscle cells, leading to a condition called cardiotoxicity. This damage can be cumulative, even with moderate doses, and can weaken the heart and affect its normal function.
Early detection of heart problems is crucial. Here are some common symptoms of cardiovascular complications to be aware of:
Cardiovascular complications associated with DLBCL treatment can range from mild to severe and ultimately lead to heart failure. Some of the most reported complications include:
During and after DLBCL treatment, it is crucial to maintain open communication with your doctor. This will ensure that any potential issues can be identified early on and addressed. Here's what you can do to minimize cardiovascular risks:
Regular monitoring with echocardiograms is crucial. If your echocardiogram results show any abnormalities, your doctor may recommend consulting with a cardiologist or a cardio-oncologist for a more specialized assessment and personalized management plan for your heart health.
While some DLBCL treatments can increase the risk of heart problems, early detection, and proactive management strategies play a significant role in minimizing these risks. By working closely with your doctor and adopting a heart-healthy lifestyle, you can significantly improve your long-term health and well-being after DLBCL treatment.
If you want to learn more about navigating your health living with DLBCL and latest treatment advances, make sure to check out our Events Page and join us in our next webinar, CAR T-Cell Therapy Advances in Large B-Cell Lymphoma.
Sources:
about the author
Lisa Foster
Lisa Foster is a mom of 3 daughters, a puzzle lover, a writer, and a HealthTree advocate. She believes in the mission of the foundation and the team that builds it forward. She calls Houston, Texas home.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.